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Summary: Haptoglobin is an acute phase protein showing a genetic polymorphism with 3 major types: Hp 1 -1, Hp 2-1,
and Hp 2-2. In this study, flow cytometric analysis demonstrated that all three haptoglobin types bind to CD22 on human
B-lymphocytes with equal affinity. Comparison of reference values for lymphocyte subsets in peripheral blood and bone
marrow showed significant differences between haptoglobin types. Haptoglobin 2-2 is associated with higher peripheral
B-lymphocyte counts (P < 0.001) and CD4+ T-lymphocyte counts (P < 0.05). In bone marrow, CD4+ T-cell percent-
ages were highest (P < 0.001) but B-cell percentages were lowest (P < 0.001) in haptoglobin 2-2 type. A negative cor-
relation between serum haptoglobin 1-1 concentration and peripheral B-cell counts was observed (r = —0.663). Our
results suggest that haptoglobin is involved in lymphocyte distribution. The present findings are a potential cause of
over- or underestimation of lymphocyte subset counts in the clinical staging of immunodeficiency diseases.
Introduction
Haptoglobin is an acute phase sialoglycoprotein with
haemoglobin-binding capacity (1). Haptoglobin is char-
acterized by a molecular heterogeneity with three main
genetic types: Hp 1-1, Hp 2-1, and Hp 2-2 (2). This
polymorphism arises from variant α-polypeptide chains
(Q! and a2), since the -polypeptide chains of the three
haptoglobin types are identical (3). The α-chains are ge-
netically determined by two autosomal alleles, Hpl and
Hp2 (3, 4). The homozygote Hp 1-1 is a small protein
(Mr = 86000) with the formula (01 )̂2 (5). The hetero-
zygote Hp 2-1 with the formula [(01 )̂2 + (α2β)η]
(η = 0, l, 2, ...) is characterized by polymerization (Mr
= 165 000) (5). In Hp 2-2 higher molecular mass forms
are found (Mr =200000) with the formula (α2β)η
(η = 3, 4, 5, ...) (5). Many functional differences be-
tween haptoglobin types have been described (6).
The protein plays an important role in the immunologi-
cal and inflammatory response (5, 6). Haptoglobin in-
hibits prostaglandin synthesis, but this anti-inflamma-
tory effect is less pronounced for Hp 2-2 (6-8). The Hp
2-2 type is over-represented among patients with auto-
immune diseases (9, 10). Hp 2-2 individuals show a
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stronger immune reactivity, as evidenced by higher anti-
body titres following vaccination (11 — 13).
Interactions of haptoglobin with neutrophils and mono-
cytes are well described (14-16), but haptoglobin bind-
ing to lymphocytes has never been investigated. Hapto-
globin is known to inhibit various forms of lectin-induced
lymphocyte transformations and there is some indication
that haptoglobin modulates B-cell proliferation (17—19).
More recently, it has been demonstrated that the carbohy-
drate moiety of human haptoglobin binds to the B-cell ad-
hesion glycoprotein CD22 (20), suggesting that haptoglo-
bin is involved in trafficking of lymphocytes. On the other
hand, B- and T-lymphocyte counts are used as a diagnos-
tic test in a number of diseases, particularly in the clinical
staging of HIV-infection (21,22).
In this study, we performed a flow cytometric analysis
of haptoglobin binding to human lymphocytes. In order
to study the physiological and clinical importance of this
binding, we investigated the relationship between hapto-
globin type and reference values for lymphocyte subsets
in peripheral blood and in bone marrow.
Materials and Methods
Subjects
A population of 107 healthy Caucasian volunteers of Flemish des-
cent was studied. Blood was obtained by venipuncture, allowed to
clot, and centrifuged (1000g, 10 minutes, room temperature). The
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supernatant serum was collected for analysis. Simultaneously
drawn peripheral blood was collected in K2EDTA-coated tubes for
cytological study. In order to reduce biological variations, blood
was drawn between 09:00 h and 10:00 h. All subjects gave in-
formed consent to participate in this study. The study group con-
sisted of 44 males (age: 40 ± 11 years) and 63 females (age: 42
±11 years). Subjects under corticoid therapy or with recent infec-
tion, vaccination (within 12 months prior to sampling), and serum
C-reactive protein concentrations > 10 mg/1 were excluded. There
was no clinical evidence of any haematological or other disease.
The haptoglobin type of the subjects was determined using starch
gel electrophoresis of haemoglobin supplemented serum, followed
by peroxid se staining (2).
Bone marrow aspirates
Human bone marrow samples were aspirated by sternal puncture
from 45 haematologically normal patients undergoing cardiac sur-
gery (33 males aged 64 ± 7 years and 12 females aged 58 ± 8
years). Informed consent was also obtained from these subjects.
Bone marrow was collected in tubes containing 10 ml RPMI 1642
medium (Gibco, Paisley, UK) and 50 μΐ sodium heparin (5 Χ 106
IU/1). The haptoglobin type was determined in serum collected
from these patients before surgery. This study was approved by the
ethical committee of the University Hospital of Gent.
Immunophenotyping of peripheral blood lymphocytes
Haematological examinations were always performed on fresh
EDTA blood. Properties measured included the total counts of leu-
kocytes and differential white blood cell count (Sysmex NE-8000,
Toa Medical Electronics Co., Kobe, Japan) (23). Lymphocyte sub-
sets were analysed by flow cytometry. For T-cell marker analysis,
5 μΐ of TriTEST™ reagent (Becton Dickinson, Mountain View,
CA, USA) were applied to 50 μΐ EDTA-blood. This reagent is a
combination of CD4-phycoerythrin, CD8-fluorescein isothiocya-
nate, and CD3-peridinin chlorophyll conjugated mouse monoclonal
antibodies (isotypes: IgGiK). B-lymphocytes were analyzed using
phycoerythrin-labelled CD19-mouse antibodies (isotype: IgGiK)
(Coulter, Hialeah, FL, USA) (5 μΙ/50 μΐ blood). Five microliters
of CD56-phycoerythrin and CD3-fluorescein isothiocyanate mouse
antibodies (isotypes: IgGjK, both purchased from Coulter) were
applied to 50 μΐ blood for the determination of Natural Killer (NK,
CD3~CD56+) cells. After incubation (4 °C, 30 minutes), erythro-
cytes were lysed by hypotonic shock and leukocytes were fixed
using a Q-Prep Workstation (Coulter, Hialeah, FL, USA). The per-
centages of lymphocyte subsets in peripheral blood were deter-
mined on a FACSort flow cytometer, equipped with the
Cellquest™ software (Becton Dickinson, Mountain View, CA,
USA). The absolute numbers of lymphocyte subsets were calcu-
lated by multiplying the percentages of CD3+-, CD3+CD4+-,
CD3+CD8+-, CD19+-, and CD3-CD56+-cells by the total
number of peripheral blood lymphocytes.
Immunophenotyping of bone marrow lymphocytes
Immediately after collection of heparinized bone marrow, mononu-
clear cells were separated by density gradient centrifugation on
Lymphoprep® (Nycomed, Oslo, Norway), washed three times in
Hank's balanced salt solution (Gibco, Paisley, UK), and resus-
pended in RPMI 1642 medium to a final cell count of 109/1. Lym-
phocyte subsets were evaluated using Simultest™ reagents Leuco-
GATE™ (CD45/CD14), Control γι/γ^ (IgGj/IgGO, CD3-fluores-
cein isothiocyanate/CD4-phycoerythrin, CD3-fluorescein isothio-
cyanate/CD8-phycoerythrin, CD3-fluorescein isothiocyanate/CD56
+ CD16-phycoerythrin, and CD3-fluorescein isothiocyanate/
CD19-phycoerythrin (Becton Dickinson). Twenty microliters of
Simultest™ reagents were applied to 100 μΐ of cell suspensions.
Phenotyping was performed on a FACSort flow cytometer, making
use of the SimulSET™ software (Becton Dickinson, Mountain
View, CA, USA).
Determination of haptoglobin and C-reactive protein
Concentrations of haptoglobin and C-reactive protein in serum
were measured by fixed-time immunonephelometry on a BN II
nephelometer (Behringwerke AG, Marburg, Germany) (24). Rabbit
anti-human protein antisera, controls, and standards were obtained
from Behringwerke. For each assay, we used one single batch of
antiserum. Calibrations were done with the same standard batch.
The serum protein concentrations were expressed according to
IFCC-standards (25, 26).
Direct haptoglobin binding to lymphocytes
Purified human haptoglobin type 1-1, 2-1, and 2-2 preparations
were a kind gift of Behringwerke AG (Marburg, Germany). The
purity of the material was checked by SDS-PAGE. Haptoglobin
types were conjugated with fluorescein isothiocyanate (Sigma
Chemical Co., St. Louis, MO, USA), (0.05 mg fluorescein isothio-
cyanate per mg haptoglobin) in a 0.25 mol/1 carbonate buffer, 0.15
mol/1 NaCl, pH 9 at 4 °C overnight. The solution was dialyzed in
order to separate haptoglobin-fluorescein isothiocyanate from free
fluorescein isothiocyanate.
For haptoglobin binding analysis, 100 μΐ of peripheral blood mono-
nuclear cell suspensions (109/1) were incubated (4 °C, 30 min) with
100 μΐ of haptoglobin-fluorescein isothiocyanate (1 g/1). Haptoglo-
bin was always applied to cells obtained from subjects of the same
haptoglobin type. In order to phenotype the haptoglobin binding
cells, 5 μΐ of phycoerythrin-labelled mouse antibodies against CD4
(IgG!K, Coulter), CDS (IgGiK, Coulter), CD3 (IgG^, Becton
Dickinson), CD 19 (IgG^, Coulter), or CD56 (IgG^, Coulter)
were applied as well. After incubation (4 °C, 30 min), the cells
were washed twice and resuspended to 0.5 ml with phosphate-
buffered saline. Flow cytometric analysis was then performed on a
FACSort flow cytometer. Lymphocytes were gated using a forward
scatter-side scatter plot.
Indirect haptoglobin detection on lymphocytes
Haptoglobin binding to lymphocytes was also investigated by indi-
rect immunofluorescence. Therefore, 100 μΐ of mononuclear cell
suspensions (109/1) were incubated (4 °C, 30 min) with 1 ml of
purified haptoglobin (1 g/1) and washed in phosphate-buffered sa-
line. In a second step, 100 μΐ of cell suspensions were incubated
(4 °C, 30 min) with 5 μΐ of sheep antihuman haptoglobin antiserum
(The Binding Site, Birmingham, UK), diluted 1 :10 in phosphate-
buffered saline, and were washed twice in phosphate-buffered sa-
line. Five microliters of donkey anti-sheep IgG-fluorescein isothio-
cyanate (The Binding Site), diluted 1 :20 in phosphate-buffered
saline, and 5 μΐ of phycoerythrin-labelled antibodies (CD4, CDS,
CD3, CD 19, CD56) were then applied to the cells. In order to
eliminate (false-positive) Fc binding of the first antibody, cells
were preincubated (4 °C, 30 min) with normal sheep Ig (Sigma
Chemical Co.). As a negative control for the second antibody, cells
were incubated with donkey anti-sheep IgG-fluorescein isothiocya-
nate and with phycoerythrin-labelled mouse antibodies only.
Affinity of haptoglobin to the plasma membrane of lymphocytes
was studied using a similar procedure but with decreasing concen-
trations of purified haptoglobin (1 g/1), diluted 1 : 2 to 1 : 1024 in
phosphate-buffered saline. The affinity constant K was calculated
using the equation
_ [occupied binding sites]
[free binding sites] [Hp]
where [Hp] represents the molar concentration of haptoglobin (27).
Interference of haemoglobin and CD22 antibodies
Human haemoglobin was purchased from Sigma Chemical Co.
(St. Louis, MO, USA). In order to study the effect of haemoglo-
bin on haptoglobin binding to lymphocytes, 10 μΐ of the haemo-
globin solution (40 g/1) were applied 15 minutes after application
of purified haptoglobin to 100 μΐ of the mononuclear cell sus-
pension (30 min, 4 °C). In order to study inhibition of haptoglo-
bin binding by CD22 antibodies, the cells were preincubated for
30 min at 4 °C with 10 μΐ of mouse anti-human CD22 antibodies
(140 mg/1) (Dako A/S, Glostrup, Denmark). In both experiments,
haptoglobin binding to lymphocytes was detected as previously
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Tab. 1 Age, gender, peripheral blood leukocyte counts, lympho-
cyte subset counts, CD4+/CD8+ Τ cell ratio, and serum haptoglo-
bin and C-reactive protein concentrations of the study population
according to haptoglobin (Hp) type.






























































































































a All values: Mean ± SD.
b Ρ < 0.05 (ANOVA).
c P < 0.001 (ANOVA).
described. The mean fluorescence and the number of positive
cells obtained without haemoglobin or anti-CD22 incubation was
equalized to 100% (control). Mean fluorescence and the number
of positive cells after incubation with haemoglobin or anti-CD22
were expressed as percentage of control. The difference between
both percentages was a measure for the degree of inhibition of
haptoglobin binding.
Statistics
Values are expressed as means ± SD. Validity of Hardy-Weinberg
equilibrium was tested using the chi-square test. Comparisons of
cell counts, cell percentages, and protein concentrations between
haptoglobin type groups were carried out using ANOVA. Corre-
lations between data were examined using regression analysis. Sta-
tistical significance was considered at the level P < 0.05. Adjust-
ment for multiple testing was done when appropriate using the
Bonferroni correction.
Results
Haptoglobin gene frequency of the
study population
In the study population, haptoglobin type frequencies
were 0.196 (Hp 1-1), 0.477 (Hp 2-1), and 0.327 (Hp 2-
2). Allele frequencies of 0.40 (Hpl) and 0.60 (Hp2)
were obtained. These results are in agreement with
Hardy-Weinberg'1 s equilibrium and with earlier studies
on Flemish subjects (13, 28). Age and gender of the
subjects according to haptoglobin type are given in
table 1.
Total and differential leukocyte counts
In peripheral blood, no differences between haptoglobin
types were found for total leukocyte counts (tab. 1). Dif-
ferential counts of granulocytes and monocytes were
comparable but total lymphocyte count was significantly
higher in haptoglobin 2-2 subjects (P < 0.05).
Peripheral blood lymphocyte subsets
The flow cytometric phenotype data presented in table
1 correspond to normal reference values for peripheral
blood lymphocyte subsets in Caucasians (29). No sig-
nificant differences were found in percentages of
CD3+-, CD3+CD4+-, CD3+CD8+-, CD19+-, and
CD3~CD56+-cells between haptoglobin types. Abso-
lute peripheral CD3+, CD3+CD8+, and CD3~CD56+
counts (109/1) were comparable as well. However,
CD3+CD4+-cell counts were significantly higher in
Hp 2-2 subjects (P < 0.05). The CD4+/CD8+ T-cell
ratio was comparable in the three groups. Furthermore,
peripheral CD19+-cell counts showed marked differ-
ences according to the haptoglobin type (P < 0.001).
In the Hp 1-1 group, peripheral CD19+ counts are
low. Hp 2-2 is associated with the highest CD19+
counts. Neither age nor gender of the subjects were
related to peripheral CD19+- and CD3+CD4+-cell
counts.
Serum haptoglobin and C-reactive protein
concentrations
The concentrations of haptoglobin measured in serum
correspond to earlier studies (tab. 1) (6, 13). In the
overall population, peripheral CD19+-cell counts were
not related to serum haptoglobin levels. However, in
the Hp 1-1 group, a negative correlation of CD19+
count with serum haptoglobin concentration was ob-
tained: y (peripheral CD19+-cells, 109/1) = -67.73*
(serum Hp 1-1 concentration, g/1) + 262.91;
r = -0.663, Syx = 44.83 (P < 0.01) (fig. 1). Such cor-
relations were not observed in Hp 2-1 and Hp 2-2
subjects. Similarly, peripheral CD3+CD4+ counts were
not related to serum haptoglobin levels. Serum C-
reactive protein concentrations were comparable be-
















Serum Hp 1-1 concentration [ g/l ]
Fig. 1 Relation between peripheral Β cell count (109/1) (y) and
serum haptoglobin (Hp) concentration (g/l) (je) in Hp 1-1 subjects:
y = -67.73* + 262.91, r = -0.663, P < 0.01, n = 21.
202 Langlois et al.: Haptoglobin polymorphism and lymphocyte distribution
Tab. 2 Lymphocyte subset percentages and CD4+/CD8+ T cell
































a All values: Mean ± SD.
b P < 0.001 (ANOVA).
c P < 0.05 (ANOVA).
Bone marrow lymphocyte subsets
In human bone marrow aspirates, percentages of
CD3+-, CD3+CD4+-, CD3+CD8+-, CD19+-, and
CD3~CD56+-cells were compared between haptoglo-
bin types. As shown in table 2, total CD3+ bone
marrow cell percentages were lowest in Hp 1-1 type
(P < 0.05), which was exclusively caused by lower
CD3+CD4+ percentages (P < 0.001). Significant dif-
ferences for CD3+CD8+ and CD3~CD56+ bone mar-
row cells were not observed. A nearly significant hap-
toglobin type-dependence of CD4+/CD8+ T-cell ratio
was obtained in bone marrow (P = 0.079). In contrast
to peripheral blood, Hp 2-2 is associated with the
lowest CD19+ bone marrow cell percentages
(P < 0.001).
Relations between bone marrow and
peripheral blood lymphocytes
Peripheral blood lymphocyte subset counts were deter-
mined in EDTA-blood obtained from 10 patients before
cardiac surgery and compared with the data obtained in
their bone marrow aspirates. Bone marrow CD3+CD4+
percentages (y) correlated positively with peripheral
CD3+CD4+ counts (x, 109/1): y = 0.03* +11.38,
r = 0.742, Syx = 7.53 (P < 0.05). In contrast, a negative
correlation was found between CD19+ bone marrow
percentages (y) and peripheral CD19+ counts (jc, 109/1):
y = -0.21* + 66.36, r = -0.779, S^ = 6.75
(P < 0.01).
Relation between serum haptoglobin
concentrations and bone marrow lymphocyte
percentages
In the overall group, no correlations were obtained be-
tween serum haptoglobin concentrations and lymphocyte
subset percentages in bone marrow. However, in Hp 1-1
subjects, CD19+ percentages correlated positively with
serum haptoglobin concentrations: y (% CD19+ bone
marrow cells) = 34.30* (serum Hp 1-1 concentration, g/1)
-7.50, r = 0.770, Syx = 7.58 (P < 0.05). This is in con-
trast with the negative correlation of Hp 1-1 concentration
with peripheral CD19+ count. In all haptoglobin types,




Figure 2 is a typical flow cytometric dot plot showing
haptoglobin-fluorescein isothiocyanate binding to the
cell-surface of CD19+-lymphocytes. Such Hp+CD19+-
cell populations were obtained with Hp 1-1 (n = 5), Hp
2-1 (n = 5), and Hp 2-2 (n = 5). No haptoglobin-fluo-
rescein isothiocyanate binding was detected on CD4+-,
CD8+-, CD3+-, and CD56+-cells. As demonstrated in
previous studies, haptoglobin binding was also observed
in the monocyte and granulocyte populations (14-16).
Indirect haptoglobin detection on
lymphocytes
Identical results were obtained after indirect haptoglobin
staining using sheep anti-haptoglobin antiserum and
donkey anti-sheep IgG-fluorescein isothiocyanate. In all
haptoglobin types, the flow cytometric dot plots of
Hp+CD19+-lymphocytes were comparable with the di-
rect haptoglobin staining (fig. 3). Control experiments
were performed in order to exclude Fc binding of the
two antibodies. Hp"l"CD19+-lymphocytes were also ob-
tained after preincubation of the cells with normal sheep
immunoglobulin. On the other hand, no Hp+CD19+
double-positive staining was observed after incubation
of the cells with donkey anti-sheep IgG-fluorescein
isothiocyanate and phycoerythrin-labelled CD 19 anti-
bodies only.
Effect of haemoglobin and CD22-antibodies
on haptoglobin binding
Flow cytometric analysis showed that the addition of
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Fig. 2 Illustration of haptoglobin (Hp) binding to Β cells. Shown
is a flow cytometric dot plot of log fluorescein isothiocyanate
(FITC) fluorescence (Hp) vs log phycoerythrin (PE) fluorescence
(CD 19) of lymphocytes. The plot was obtained after incubation of
peripheral blood mononuclear cells with human Hp-FITC and
mouse anti-CD 19 PE.
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nificant reduction of Hp 1-1 (n = 3), Hp 2-1 (n = 3),
or Hp 2-2 (n = 3) binding to CD19+-lymphocytes. In
contrast, binding of haptoglobin to CD 19+-lymphocytes
could be inhibited by preincubation of the cells with
CD22 antibodies. The CD22 antibodies reduced the
mean fluorescein isothiocyanate fluorescence by 78
± 5% and the number of positive cells by 96 ± 2%
(n = 9). Comparable results were obtained for all three
haptoglobin types.
Affinity of haptoglobin towards CD22
The affinity constants Κ observed for Hp-CD22 binding
were 2.62 ± 0.53 ΙΟ7 ηιοΓ1 X 1 (Hp 1-1; n = 5), 2.71
± 1.52 107 mol~1 X 1 (Hp 2-1; n = 5), and 3.20 ± 1.47
ΙΟ7 ηιοΓ1 X 1 (Hp 2-2; n = 5). Figure 4 shows the
bound/free ratios (occupied CD22 binding sites/free
CD22 binding sites) at increasing molar concentrations
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Fig. 3 Indirect detection of haptoglobin (Hp) binding to B cells.
The flow cytometric dot plot showing log fluorescein isothiocya-
nate (FITC) fluorescence (Hp) vs log phycoerythrin (PE) fluores-
cence (CD 19) was obtained after incubation of lymphocytes with
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Fig. 4 Binding of Hp types 1-1, 2-1, and 2-2 to Β lymphocytes.
Shown are the B/F ratios (bound/free) of CD22 binding sites at
increasing molar Hp concentrations. The percentages of Hp-bind-
ing CD19+ lymphocytes were multiplied by the mean FITC fluo-
rescence of the positive CD19+ cell populations. The B/F ratios
were calculated from the maximum Hp-CD22 saturation: B/F =
[observed binding]/[maximal binding — observed binding].
1 · Hp 1-1, 2 A Hp 2-1, 3 · Hp 2-2
present on B-lymphocytes (30). Taking into account the
calculated mean B-cell counts (tab. 1), this corresponds
to CD22 molecule number concentrations of approxi-
mately 1.7 X 1012/1 (Hp 1-1), 2.1 X 1012/1 (Hp 2-1), and
2.6 X 1012/1 (Hp 2-2) in peripheral blood. From the
mean molar concentrations of haptoglobin types 1-1 (14
X 10~6 mol/1), 2-1 (6 X 10~6 mol/1), and 2-2 (2.85
X 10~6 mol/1), we can estimate that a negligible fraction
(< 0.0001%) of plasma haptoglobin is present on B-
lymphocytes. However, the occupation of CD22 mole-
cules by haptoglobin is type-dependent: the percentages
of free CD22 molecules are approximately 0.25% (Hp
1-1), 0.70% (Hp 2-1), and 1.20% (Hp 2-2).
Discussion
Flow cytometric analysis demonstrated that haptoglobin
binds to human B-lymphocytes in Hp 1-1, Hp 2-1, and
Hp 2-2 individuals. In contrast, no significant binding
was detected for T-cells and NK-cells.
The values for the affinity constant observed for hapto-
globin binding (2.80 ± 0.53 107 mol"1 X 1) are in
agreement with those found by Hanasaki et al. who de-
monstrated that the carbohydrate moiety of the hapto-
globin -chain binds to human recombinant CD22 (20).
The affinity constants were comparable for the three
haptoglobin types. This is not surprising, since the hap-
toglobin -chain is identical in all haptoglobin types.
However, the number of free CD22 binding sites were
estimated to be higher in Hp 2-2 blood.
Antibodies to CD22 block haptoglobin binding to fi-
celle, indicating that CD22 is indeed the binding site for
haptoglobin. In contrast, addition of haemoglobin had
no effect on haptoglobin binding to B-cells. Although
the binding of haemoglobin to the -chain of haptoglo-
bin is characterised by a very high affinity (> 1010
mol"1 X 1) (31), it does not interfere with the haptoglo-
bin-CD22 binding. This suggests that the haptoglobin -
binding region for CD22 is different from the haemoglo-
bin-binding site.
Reference values for peripheral blood lymphocytes dif-
fer significantly depending on the haptoglobin type. To-
tal peripheral blood lymphocyte counts are highest in
Hp 2-2 individuals, which is exclusively caused by
higher B-cell and helper T-cell counts. This effect was
even more pronounced in bone marrow helper T-cell
percentages. In contrast, the lowest B-cell percentages
were observed in bone marrow aspirates from Hp 2-2
subjects. Haptoglobin type dependence was not ob-
served for cytotoxic/suppressor T-cells and NK-cells in
both peripheral blood and bone marrow.
The association of Hp 2-2 type with a higher number
of peripheral circulating B-lymphocytes and helper T-
lymphocytes partly explains the strong immunological
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reactivity in Hp 2-2 individuals (5, 6). The present find-
ings can improve the interpretation of lymphocyte subset
analysis in the practice of laboratory medicine, since B-
and T-cell counts are used as a diagnostic test in a
number of diseases, such as primary or acquired immu-
nodeficiencies and sarcoidosis (21).
Particularly, the knowledge of the patients' haptoglobin
type is of interest for the interpretation of CD4+ T-cell
counts in the clinical staging of HIV-infected patients
(22). Clinicians using the fixed classification criteria of
HIV-disease may overestimate CD4+ T-cell counts in
Hp 2-2 patients (22). Therefore, absolute CD4+ T-cell
counts should be interpreted with caution.
Measurements of serum haptoglobin concentration cor-
respond to earlier studies and showed lowest haptoglo-
bin levels in Hp 2-2 individuals (6, 13). The distribution
volume of haptoglobin is about 1.5 times the plasma
volume, so the measured serum concentration is in equi-
librium with the concentration in bone marrow (4). The
association of the haptoglobin type with reference val-
ues for B-cells and CD4+ T-cells cannot be explained
by an effect of haptoglobin concentration. However, se-
rum Hp 1-1 concentration showed a negative correlation
with peripheral B-lymphocyte count. In bone marrow,
serum Hp 1-1 concentration correlated positively with
B-cell percentage. These findings suggest a negative ef-
fect of Hp 1-1 on the number of peripheral circulating
B-lymphocytes. Such correlations were not observed in
the Hp 2-1 and Hp 2-2 groups.
Peripheral helper T-lymphocyte counts correlated posi-
tively with bone marrow helper T-cell percentages.
However, for the B-cell markers, an inverse relation
was observed between peripheral counts and bone
marrow percentages. These observations support the
view of Hanasaki et al. who postulated a role for
haptoglobin in homing and trafficking of B-lympho-
cytes (20).
A lectin-like binding of haptoglobin to lymphocytes
has been suggested by several authors (5, 6). Using a
flow cytometric approach, we confirmed here the re-
cent finding that haptoglobin binds to CD22 (20).
CD22 is a cell-surface phosphoglycoprotein found on
the majority of B-lymphocytes (32). The glycoprotein
is a member of the immunoglobulin superfamily and
is involved in antigen-induced B-cell activation and
signal transduction (32, 33). CD22 is also an adhesion
receptor and mediates interactions of B-cells with
erythrocytes, T-lymphocytes, monocytes, neutrophils,
and endothelial cells by specific binding to glycopro-
teins containing N-linked oligosaccharides with termi-
nal a2-6-linked sialic acid residues (34, 35). Addition-
ally, CD22 has a function in T-cell activation via
binding to CD45RO, a T-cell surface glycoprotein
which modulates the signal transduced by the T-cell
receptor (CD3/TCR complex) (36, 37).
The haptoglobin ß-chain contains terminal a2-6 linked
sialic acid residues (38), and is capable to inhibit the
CD22 binding to TNF-a-activated human umbilical vein
endothelial cells (20). Our data demonstrate an impor-
tant biological effect of haptoglobin on B-lymphocyte
distribution as well, and further support earlier indic-
ations that haptoglobin modulates lymphocyte prolifera-
tion (28). Antibody production, however, is not influ-
enced by the haptoglobin type: reference values for se-
rum immunoglobulins are not type-dependent, except
for IgA (39).
Many questions remain to be answered. These include:
how can the haptoglobin type-dependence of B-cell ref-
erence values be explained? Hp 1-1, Hp 2-1, and Hp 2-
2 differ in a-polypeptide chain composition and in the
presence of high molecular mass forms (4). Therefore, it
is possible that the biological effect of Hp-CD22 binding
depends upon the presence or absence of multiple ar or
a2-polypeptide chains in a specific orientation or confor-
mation. Furthermore, the molar concentrations of Hp 2-
2 in serum are low due to the presence of higher poly-
mers, and the number of CD22 molecules occupied by
haptoglobin is lowest in Hp 2-2.
It also remains to be explained why reference values for
CD4+ T-cells are influenced by the haptoglobin type.
Since CD22-CD45 binding regulates TCR-mediated sig-
nal transduction (36, 37), haptoglobin may also partici-
pate in T-B-cell interaction. This could result in a nega-
tive or positive regulation of T-cell proliferation (36,
37).
Conclusion
We have demonstrated that Hp 1-1, Hp 2-1, and Hp 2-2
bind to CD22 on the cell-surface of human B-lympho-
cytes. Haptoglobin type is associated with the numbers
of B-lymphocytes and helper T-lymphocytes present in
peripheral blood and in bone marrow. This view pro-
vides new insights in the immunoregulatory mechanism
of haptoglobin and improves the interpretation of lym-
phocyte subset analysis, particularly in the clinical stag-
ing of HIV-infection.
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